The Efficacy of MK-8291 in Participants With Post-herpetic Neuralgia (PHN) With Allodynia (MK-8291-012)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This study aims to determine whether MK-8291 is effective in reducing pain in participants with post-herpetic neuralgia (PHN) with allodynia. The primary hypothesis is that when compared to placebo, treatment with MK-8291 reduces the change from Baseline in participant-reported pain intensity by 1 on an 11-point numeric rating scale.
Epistemonikos ID: ff1d9a3e467ad87634af08e5130b29e324556bd8
First added on: May 12, 2024